Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
New York State Psychiatric Institute
280 participants
Mar 17, 2022
INTERVENTIONAL
Conditions
Summary
Two-hundred and eighty individuals with schizophrenia who have a recent history of violent acts will be randomized in this 2-arm, parallel-group, 24-week, open-label, 7-site clinical trial to examine the effects of treatment with clozapine vs antipsychotic treatment as usual (TAU) for reducing the risk of violent acts in real-world settings
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
treatment will occur naturalistically, as per standard clinical guidelines
naturalistic treatment with any other antipsychotic medication except clozapine
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05208190